Ginkgo Bioworks Holdings (DNA) EBT Margin (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly EBT Margin of 390.98% for Q1 2026, down 17329.0% year-on-year from N/an in Q1 2025, and down 60.42% on a QoQ basis from 243.72% in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of EBT Margin data on file, last reported at 390.98% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 17329.0% year-over-year to 390.98%; the trailing twelve-month figure through Mar 2026 stood at 211.5% (down 701.0% YoY), and the FY2025 full-year result was 184.3%, up 5684.0% from the prior year.
- EBT Margin for Q1 2026 stood at 390.98%, down from 243.72% in the prior quarter.
- Across five years, EBT Margin topped out at 63.76% in Q3 2024 and bottomed at 1009.31% in Q3 2022.
- The 5-year median for EBT Margin is 253.88% (2023), against an average of 350.39%.
- Peak annual rise in EBT Margin reached 89018 bps in 2022, while the deepest fall reached 87709 bps in 2022.
- A 5-year view of EBT Margin shows it stood at 191.13% in 2022, then tumbled by 219 bps to 609.67% in 2023, then jumped by 60 bps to 245.99% in 2024, then gained by 1 bps to 243.72% in 2025, then slumped by 60 bps to 390.98% in 2026.
- The last three EBT Margin figures came in at 390.98% (Q1 2026), 243.72% (Q4 2025), and 207.93% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -390.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -390.98% |
| Dec 31, 2025 | -243.72% |
| Sep 30, 2025 | -207.93% |
| Jun 30, 2025 | -122.13% |
| Mar 31, 2025 | -217.69% |
| Dec 31, 2024 | -245.99% |
| Sep 30, 2024 | -63.76% |
| Jun 30, 2024 | -386.06% |
| Mar 31, 2024 | -437.17% |
| Dec 31, 2023 | -609.67% |
| Sep 30, 2023 | -546.48% |
| Jun 30, 2023 | -215.03% |
| Mar 31, 2023 | -253.88% |
| Dec 31, 2022 | -191.13% |
| Sep 30, 2022 | -1,009.31% |
| Jun 30, 2022 | -463.71% |
| Mar 31, 2022 | -351.99% |
| Dec 31, 2021 | -1,081.31% |
| Sep 30, 2021 | -132.21% |
| Jun 30, 2021 | -125.80% |
| Mar 31, 2021 | -169.94% |
| Dec 31, 2020 | -144.71% |
| Sep 30, 2020 | -196.36% |